Ovid Therapeutics Inc. (OVID) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Ovid Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -6.90x | -2.50x | -4.34x | -2.42x | 1.76x | -1.67x |
| P/B Ratio | 0.92x | 0.97x | 2.59x | 0.99x | 1.21x | 3.09x |
| P/S Ratio | 16.57x | 116.97x | 579.77x | 87.17x | 1.04x | 10.70x |
| Profitability | ||||||
| Gross Margin | 95.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -585.2% | -10933.7% | -15122.7% | -3696.4% | 59.6% | -645.4% |
| Net Margin | -240.1% | -4670.1% | -13351.8% | -3604.7% | 58.9% | -642.3% |
| EBITDA Margin | -581.1% | -10207.1% | -14544.1% | -3604.5% | 59.7% | -643.0% |
| Liquidity | ||||||
| Current Ratio | 10.91x | 5.32x | 9.55x | 18.79x | 12.87x | 3.39x |
| Quick Ratio | 10.91x | 5.32x | 9.55x | 18.79x | 12.87x | 3.39x |
| Leverage | ||||||
| Debt/Equity | 0.10x | 0.22x | 0.18x | 0.13x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..